期刊文献+

人CD59 RNAi逆转录病毒载体系统的构建与鉴定 被引量:3

CONSTRUCTION AND IDENTIFICATION OF RETRO RNAi SYSTEM OF THE SPECIFIC SILENCING CD59
下载PDF
导出
摘要 目的利用siRNA表达载体法构建并筛选携带针对CD59基因pSUPER retro RNAi逆转录病毒载体及稳定产毒的细胞克隆。方法用DNA重组技术,将3条60bp能转录产生靶向CD59小发夹RNA(shRNA)的寡核苷酸序列定向克隆入逆转录病毒载体pSUPER retro,脂质体法转染包装细胞系Phoenix A,建立产生逆转录病毒的细胞克隆。结果重组载体经PCR及限制性内切酶酶切鉴定初步成功后测序序列正确;重组载体转染包装细胞,可表达绿色荧光蛋白,表明包装成功。结论特异性沉默CD59基因的pSUPER retro RNAi逆转录病毒载体以及稳定产毒的细胞系构建成功,为后续进行肿瘤细胞的研究奠定了基础,可望为肿瘤治疗开辟新途径。 Objective To construct recombinant retroviral vectors that target CD59 gene and a stable virus-producing cell line. Methods Three 60 bp encoded targeting CD59 gene shRNA sequences were cloned into pSUPER with DNA recombinant technique. The packaging cell Phoenix A was transfected with this recombinant plasmids using liposome. Results The result of electrophoresis of PCR, enzyme digestion and sequence demonstrated that 60 bp had been inserted into the vector. And virus-producing cell lines were selected. Conclusion Recombinant retroviral vectors and stable virus-producing packaging cell lines are successfully constructed and identified, which opens up a way for studying the role of CD59 in the immune escape of tumor cells and in tumor therapy.
出处 《青岛大学医学院学报》 CAS 2009年第1期1-3,共3页 Acta Academiae Medicinae Qingdao Universitatis
基金 国家自然科学基金资助项目(30671936)
关键词 RNA 双链 抗原 CD59 转染 逆转录病毒载体 RNA, double-stranded Antigens, CD59 Transfection Retroviral vector
  • 相关文献

参考文献7

  • 1FONSATTI E, ALTOMONTE M, CORAL S. Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies[J]. Clin Ter, 2000,151(3) : 187-193.
  • 2FISHEISON Z, DONIN N, ZELL S, et al. Obstacles to cancer immunotherapy, expression of membrane complement reg ulatory proteins (mCRPs) in tumors[J]. Mol Immunol, 2003, 40(2/4) : 109-123.
  • 3DEN C, FONSATTI E, SIGALOTTI L, et al. Recombinant transmembrane CD59 (CD59 TM) confers complement resis- tance to GPI-anchored protein defective melanoma cells[J]. J Cell Physiol, 2002,190 (2) : 200-206.
  • 4MERI S, MORGAN B P, DAVIES A, et al. Human protectin (CD59), an 18,000--20,000 MW complementlysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers[J]. Immunology, 1990,71:1 9.
  • 5BRUMMELKAMP T R, BERNARDS R, AAMI R, et al. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science, 2002,296: 550.
  • 6SUI G, SOOHOO C, AFFAREL B, et al. A DNA vector based RNAi technology to suppress gene expression in mam- malian cells[J]. Proc Natl Acad Sci USA, 2002, 99: 5515- 5520.
  • 7徐华敏,姜宏,谢俊霞.细菌内同源重组构建携带人DMT1基因的重组腺病毒[J].青岛大学医学院学报,2008,44(3):189-191. 被引量:2

二级参考文献2

共引文献1

同被引文献26

  • 1郭林,白云.GPI锚固蛋白与T细胞活化信号转导[J].免疫学杂志,2000,16(z1):9-14. 被引量:7
  • 2朱有凯,林汉良,顾霞,张萌,吴红阳,许湘.shRNA干扰Jurkat细胞株MDM2表达对细胞生物特性的影响[J].临床与实验病理学杂志,2005,21(3):347-350. 被引量:3
  • 3秦诚,蔡小勇.补体调节蛋白CD46、CD55及CD59在肿瘤免疫治疗中的研究进展[J].癌症,2006,25(11):1450-1453. 被引量:19
  • 4FARKAS I,BARANYI L,ISHIKAWA Y,et al.CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9[J].J Physiology,2002,539(2):537-545.
  • 5BROOIMANS R A,VAN WIERINGEN P A,VAN ES L A,et al.Relative roles of decay-accelerating factor,membrane cofactor protein,and CD59 in the protection of human endothelial cells against complement-mediated lysis[J].Eur J Immunol,1992,22(12):3135-3140.
  • 6MIYAGAWA S,SHIRAKURA R,MALSUMIGA G,et al.Possible of prevention of hyperacute rejection by DAF and CD59 in xenotansplantation[J].Transplant Proc,1994,26(3):1235-1238.
  • 7FISHEISON Z,DONIN N,ZELL S,et al.Obstacles to can-cer immunotherapy:expression of membrane complement regulatory proteins (mCRPs) in tumors[J].Mol Immunol,2003,40(2-4):109-123.
  • 8FONSATTI E,ALTOMONTE M,CORAL S.Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies[J].Clin Ter,2000,151(3):187-193.
  • 9GAVIN P D,LLOYD J O,ROBERT D S.The immunobiology of cancer immunosurveillance and immunoediting[J].Immunity,2004,21(2):137-148.
  • 10FIRE A,XU S,MONTGOMERY M K,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabdits elegans[J].Nature,1998,391(6669):806-811.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部